Hwang Ji-Sun, Park Ji-Won, Nam Moon-Suk, Cho Hyeongjin, Han Inn-Oc
Department of Physiology and Biophysics, College of Medicine, Inha University, Incheon, Republic of Korea.
Department of Life Science, Inha University, Incheon, Republic of Korea.
Metabolism. 2015 Mar;64(3):368-79. doi: 10.1016/j.metabol.2014.11.005. Epub 2014 Nov 20.
This study investigated the potential of glucosamine (GlcN) to affect body weight gain and insulin sensitivity in mice normal and at risk for developing diabetes.
Male C57BL/6J mice were fed either chow diet (CD) or a high fat diet (HFD) and the half of mice from CD and HFD provided with a solution of 10% (w/v) GlcN. Total cholesterol and nonesterified free fatty acid levels were determined. Glucose tolerance test and insulin tolerance test were performed. HepG2 human hepatoma cells or differentiated 3T3-L1 adipocytes were stimulated with insulin under normal (5 mM) or high glucose (25 mM) conditions. Effect of GlcN on 2-deoxyglucose (2-DG) uptake was determined. JNK and Akt phosphorylation and nucleocytoplasmic protein O-GlcNAcylation were assayed by Western blotting.
GlcN administration stimulated body weight gain (6.58±0.82 g vs. 11.1±0.42 g), increased white adipose tissue fat mass (percentage of bodyweight, 3.7±0.32 g vs. 5.61±0.34 g), and impaired the insulin response in livers of mice fed CD. However, GlcN treatment in mice fed HFD led to reduction of body weight gain (18.02±0.66 g vs. 16.22±0.96 g) and liver weight (2.27±0.1 vs. 1.85±0.12 g). Furthermore, obesity-induced insulin resistance and impaired Akt insulin signaling in the liver were alleviated by GlcN administration. GlcN inhibited the insulin response under low (5 mM) glucose conditions, whereas it restored the insulin response for Akt phosphorylation under high (25 mM) glucose conditions in HepG2 and 3T3-L1 cells. Uptake of 2-DG increased upon GlcN treatment under 5 mM glucose compared to control, whereas insulin-stimulated 2-DG uptake decreased under 5 mM and increased under 25 mM glucose in differentiated 3T3-L1 cells.
Our results show that GlcN increased body weight gain and reduced the insulin response for glucose maintenance when fed to normal CD mice, whereas it alleviated body weight gain and insulin resistance in HFD mice. Therefore, the current data support the integrative function of the HBP reflecting the nutrient status of lipids or glucose and further implicate the importance of the pathway in insulin signaling for the regulation of metabolism.
本研究调查了氨基葡萄糖(GlcN)对正常及有患糖尿病风险的小鼠体重增加和胰岛素敏感性的影响。
雄性C57BL/6J小鼠分别喂食普通饮食(CD)或高脂饮食(HFD),CD组和HFD组各一半小鼠给予10%(w/v)GlcN溶液。测定总胆固醇和非酯化游离脂肪酸水平。进行葡萄糖耐量试验和胰岛素耐量试验。在正常(5 mM)或高糖(25 mM)条件下,用胰岛素刺激HepG2人肝癌细胞或分化的3T3-L1脂肪细胞。测定GlcN对2-脱氧葡萄糖(2-DG)摄取的影响。通过蛋白质免疫印迹法检测JNK和Akt的磷酸化以及核质蛋白O-GlcNAc化。
给予GlcN促进了体重增加(6.58±0.82 g对11.1±0.42 g),增加了白色脂肪组织脂肪量(占体重的百分比,3.7±